US: DSRLF - DiaSorin S.p.A

Rentabilität für sechs Monate: +9.75%
Dividendenrendite: +1.14%

Aktionsplan DiaSorin S.p.A

Erweiterter Zeitplan Einfaches Diagramm
Financial Markets by TradingView

Über das Unternehmen DiaSorin S.p.A

DiaSorin S.p.A. engages in development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, Africa, North America, Central and South America, the Asia Pacific, and China. The company provides various immunodiagnostic LIAISON platforms, including LIAISON XS, LIASON IQ, LIAISON XL, LIAISON XXL, and LIAISON XL LAS.

weitere details
It also offers molecular diagnostics platforms comprising of LIAISON NES, a new molecular platform to address the growing diagnostic decentralization trend; the ARIES and ARIES M1 systems; LIAISON MDX, a thermocycler with two consumable disc options; LIAISON MDX Plus; MAGPIX System; Luminex 100/200 System; VERIGENE System; and the LIAISON PLEX System. It has partnership agreements with QIAGEN for diagnostic solution for Latent Tuberculosis detection; TTP for the development of molecular Point-of-Care solution; and MeMed for the launch of a test differentiating between viral and bacterial infections. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Zur Vergleichsliste hinzufügen
Auf die Beobachtungsliste
Zum Portfolio hinzufügen
Preishinweis hinzufügen

Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 1.14
Дивиденд ао 1.14
Сайт https://diasoringroup.com/en
Цена ао 109.6
Preisänderung pro Tag: 0% (109.6)
Preisänderung pro Woche: 0% (109.6)
Preisänderung pro Monat: +9.32% (100.26)
Preisänderung über 3 Monate: +2.57% (106.854)
Preisänderung über sechs Monate: +9.75% (99.86)
Preisänderung pro Jahr: -19.64% (136.39)
Preisänderung seit Jahresbeginn: +2.57% (106.854)
Alle Parameter

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 1.14 2.85
DSI 0.9286 9.29
Gesamt: 4.41

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 58.92 7
Rentabilität Ebitda, % 16.73 3
Rentabilität EPS, % 4.65 1
Gesamt: 3.4
Weitere Details

Aufsicht Berufsbezeichnung Zahlung Geburtsjahr
Mr. Carlo Rosa CEO, GM & Executive Director 1966 (59 Jahre)
Dr. Chen Menachem Even Chief Commercial Officer, Senior Corporate VP of Commercial Operations & Executive Director 1963 (62 Jahr)
Mr. Piergiorgio Pedron Senior Corporate VP, CFO & Corporate Accounting Documents Officer 1971 (54 Jahr)
Mr. Fabrizio Piercarlo Bonelli Corporate VP & Chief Technology Officer
Dr. Riccardo Fava Corporate Vice President of Communication, ESG & Investor Relations
Mr. Ulisse Spada Corporate VP, Head of the Legal Department, Secretary & General Counsel
Mr. Stefano Ronchi Senior Corporate Vice President of Human Resources 1960 (65 Jahre)
Mr. Angelo Rago President of Luminex Corporation 1963 (62 Jahr)

Adresse: Italy, Saluggia, Via Crescentino - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://diasoringroup.com/en